• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Paul H. Sartori, MD named new VP at B&L

Article

Bausch & Lomb announced that Paul H. Sartori, PhD, will join the company as corporate vice president and chief human resources officer on March 17.

Rochester, NY-Bausch & Lomb (B&L) announced that Paul H. Sartori, PhD, will join the company as corporate vice president and chief human resources officer on March 17.

Most recently he was senior vice president of organizational development and human resources for Boston-based BioTrove Inc. He has more than two decades of experience in the healthcare, pharmaceutical, and diagnostic industries.

He was a partner and principal at CHM Partners International, LLC, the international executive search and management consulting firm, from 2000 to 2007. Dr. Sartori has also served as executive vice president, External Affairs and Human Resources at Novartis; senior vice president of Human Resources and Communications at CIBA-Geigy; and global vice president of Human Resources at CIBA-Corning Diagnostics. He has held teaching and administrative roles at the University of Virginia and James Madison University.

"I've known Paul for more than 20 years, and have great respect for his business judgment," said Gerald M. Ostrov, B & L chairman and chief executive officer. "He has the ability to develop superior talent, and a sterling reputation for working with organizations to improve their effectiveness. We're fortunate that he's chosen to join Bausch & Lomb as we enter an extended period of growth."

David R. Nachbar, current chief human resources officer for Bausch & Lomb, has decided to leave the company after a transition period. He is considering various options including as-yet unnamed public service opportunities.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.